Adma Biologics reported 29.73 in PE Price to Earnings for its fiscal quarter ending in December of 2025.





Pe Change Date
Adma Biologics 29.73 12.48 Dec/2025
Alnylam Pharmaceuticals 80.04 90.66 Mar/2026
BioCryst Pharmaceuticals 6.06 1.07K Dec/2025
Novavax 2.01 1.07 Dec/2025
Takeda 235.05 184.95 Dec/2025